Related Experiment Video
Updated: Jun 19, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly
Fleur Descoutures1, Dominique Himbert, Laurent Lepage
1Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Cardiology, Bichat-Claude Bernard Hospital, 46 rue Henri Huchard, 75018 Paris, France.
Insights
Elderly patients with severe aortic stenosis (AS) often present with high surgical risk. Percutaneous aortic valve interventions offer new treatment options for these high-risk individuals.
Area of Science:
- Cardiology
- Interventional Cardiology
- Geriatric Medicine
Background:
- Severe symptomatic aortic stenosis (AS) poses a significant management challenge, particularly in elderly patients.
- Traditional surgical valve replacement may not be suitable for all patients due to high operative risk.
Purpose of the Study:
- To evaluate patient characteristics, treatment strategies, and outcomes for severe symptomatic AS at a tertiary center.
- To assess the impact of on-site surgical and percutaneous valvular interventions.
Main Methods:
- Retrospective analysis of 66 consecutive patients over 70 years old with severe AS.
- Assessment of predicted surgical risk using logistic European System for Cardiac Operative Risk Evaluation and Society of Thoracic Surgeons-Predicted Risk of Mortality scores.
- Evaluation of treatment pathways including surgical valve replacement, transfemoral aortic valve implantation, medical management, and valvuloplasty.
Main Results:
- 59% of referred patients were deemed high-risk or inoperable.
- Transfemoral aortic valve implantation was performed in 12 high-risk patients.
- In-hospital mortality was 9%, with subsequent 6-month mortality of 10% among survivors, varying by treatment modality.
Conclusions:
- A substantial proportion of elderly patients with severe AS are high-risk surgical candidates.
- Percutaneous aortic valve interventions expand treatment options for elderly patients with severe AS.
- Multidisciplinary evaluation is crucial for optimizing management in this complex patient population.
Aims:
To assess patient characteristics, therapeutic options, and their results in patients referred to a tertiary centre with on-site capabilities for surgical and percutaneous valvular interventions for the management of severe symptomatic aortic stenosis (AS).
Methods And Results:
Sixty-six consecutive patients >70 years (83 +/- 6 years) were referred for severe AS. Their mortality risk predicted by the logistic European System for Cardiac Operative Risk Evaluation and the Society of Thoracic Surgeons-Predicted Risk of Mortality scores were on average 20 +/- 14% and 17 +/- 7%, respectively. Thirty-nine patients (59%) were considered at high-risk for surgery or inoperable after multidisciplinary evaluation: 12 (31%) underwent a transfemoral aortic valve implantation and 27 were considered unsuitable and treated medically (n = 16) or with valvuloplasty (n = 7), or were re-directed towards surgery (n = 4). The 27 other patients underwent valve replacement. In-hospital mortality was 9% (6 of 66). There were three hospital deaths in patients treated percutaneously, two in those treated medically, and one after surgery. At 6 months, 10% (6 of 60) of the survivors died: two after valvuloplasty and four after medical treatment.
Conclusion:
A large proportion of elderly patients referred for management of severe AS have a high-risk profile. The availability of percutaneous valvular interventions increases the number of those who are offered interventions.
Related Concept Videos
Mitral Stenosis III: Medical Management
Aortic Regurgitation III: Medical Management
Atherosclerosis III: Management
Peripheral Artery Disease III: Interprofessional Care
Aneurysm III: Interprofessional Care
Aneurysm IV: Nursing Management

